Schuster III Russell E.
Known title: Chief Commercial OfficerCIK: 0002048040
Associated companies
Transaction History
| AHCO | ▼ Sell | Open Market | 11,275 | $118K | 7/1/2026 | View on chart |
| AHCO | ▼ Sell | Open Market | 11,275 | $113K | 6/1/2026 | View on chart |
| AHCO | ▲ Buy | Grant | 48,807 | $0 | 1/30/2026 | View on chart |
| AHCO | ▲ Buy | Grant | 48,409 | $0 | 2/1/2025 | View on chart |
| AHCO | ▲ Buy | Grant | 50,597 | $0 | 2/1/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list
A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.